During the recent EuroPCR 22 conference in Paris, the results from the ARCH trial showed substantial benefits to patients who were given a potassium ferrate hemostatic patch instead of a conventional dressing following radial PCI. The BHF CRC’s clinical lead, Prof Rod Stables was a senior investigator in the trial and noted that while he’d expected to see a benefit with the patch over standard dressings plus compression, he was “shocked” by the magnitude of the difference, saying that the results have the potential to be practice-changing for his hospital and others. Read more about the results from this exciting trial and implications for better and more cost effective patient care.
EuroPCR 22 features exciting results from the single-center ARCH trial
Share this article